Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Capital Gains: Ex-NSA Chief Raises $33 Million, Thiel and Soros Team Up and More

The former spymaster scored money from Kleiner Perkins.

Todd Bernard

Former National Security Agency Director Keith Alexander’s startup raised more than $30 million from Kleiner Perkins Caufield & Byers this week, and financier George Soros invested with Peter Thiel in a bond-trading startup. Here’s the funding news from Silicon Valley:

  • Iconiq Capital, the investment firm that manages the money of Silicon Valley executives like Mark Zuckerberg and Jeff Weiner, led an $85 million investment in the enterprise technology startup Alteryx, alongside Insight Venture Partners and Meritech Capital Partners. Alteryx’s valuation is reportedly somewhere around $1 billion (New York Times).
  • Online art-auction service Paddle8 raised $34 million in Series C funding from a group of investors that includes art dealer David Zwirner, artist Rolf Sachs, Working Title Films Co-Chair Eric Fellner and Sony Music CEO Edgar Berger (ARTnews).
  • Brandwatch, a British startup that does “social intelligence” (it closely monitors and mines social media data for clients), raised $33 million from Partech Ventures, Highland Capital Partners Europe and Nauta Capital (Forbes).
  • Kleiner Perkins, Trident Capital and others invested $32.5 million in IronNet Cybersecurity, the counter-hacking startup founded by former NSA director and retired four-star general Keith Alexander (The Wall Street Journal).
  • French human resources software maker Talentsoft landed a $27.6 million investment from Goldman Sachs (Bloomberg Business).
  • Peter Thiel and billionaire fund manager George Soros are leading a $25 million investment in the Internet bond-trading startup TruMid. Former Goldman Sachs exec Jeff Bahl also participated in the round, which values the company at over $100 million (Bloomberg Business).
  • Israeli data analysis startup Signals Group raised $15 million in a Series B funding round led by Sequoia, with participation from TPY Capital (Globes).
  • Utah-based Boombox, which makes stuff like quizzes and polls for digital publishers, raised $5.5 million in Series A funding from investors that included Pelion Venture Partners (Utah Business).

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh